Ryan Israel on Investing Beyond AI

Pershing Square CIO Ryan Israel discusses the firm’s focus on durable businesses at attractive prices, highlighting Alcon and Netflix as long-term investment cases. He also addresses when macro bets make sense and the firm’s expansion into private growth companies, against a backdrop of retreating AI stocks and continued rate concerns.

Analysis

This is a capital-allocation signal, not a new earnings catalyst. In a higher-rate regime, the key test for both Alcon and Netflix is whether cash generation and reinvestment returns can support their valuations without relying on falling discount rates. For Alcon, procedure demand and recurring products may provide a different earnings profile from consumer-facing growth stocks, but elective-care sensitivity, foreign exchange and competition from Johnson & Johnson and Bausch + Lomb remain relevant checks. For Netflix, pricing, advertising monetization and content returns matter more than broad AI enthusiasm; sustained content costs or weaker engagement could undermine the durable-business thesis even if the market rewards cash generation.

The near-term risk is continued multiple compression if yields rise or investors keep reducing exposure to growth. Over 1–3 months, earnings, guidance and evidence of operating durability should matter more than this interview. Over 6–18 months, a persistent higher cost of capital would favor businesses that fund growth internally and pressure less-proven private growth assets through lower comparable-company valuations and slower liquidity. The contrarian point: “durable” is not synonymous with “cheap.” Without valuation, forecast and position-size data, the interview does not establish that either public company offers attractive risk-adjusted upside.

Key Decisions for Investors

• No trade solely on the interview. Put NFLX and ALC on a valuation-and-fundamentals watchlist; verify current multiples, free-cash-flow expectations and guidance before initiating exposure.
• For NFLX, monitor engagement, advertising contribution, pricing and content-spend discipline. A thesis requiring multiple expansion is vulnerable to higher yields; deterioration in these operating indicators would falsify the durability case.
• For ALC, track procedure trends, product mix, currency effects and competitive commentary. Weak procedure demand or guidance cuts would challenge the defensive-growth framing; consider Johnson & Johnson or Bausch & Lomb only as research comparables, not automatic hedges.
• Treat Pershing Square’s private-growth expansion as a potential duration and liquidity exposure, not proof of near-term public-market demand. Reassess if rates rise materially or comparable-company valuations weaken; verify deployment pace and valuation methodology before drawing conclusions.